Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02460822 · ClinicalTrials.gov registry record · NA
Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02460822 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 16 participants.
The verdict
NCT02460822, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This research project addresses critical gaps in cancer symptom management through the creation of a mobile chemotherapy symptom management application. This application will assess for the presence and severity of common chemotherapy side-effects and provide personally tailored symptom-related video and narratives to enhance self-management of cancer and treatment-related symptoms. This study will examine patient acceptance and use of this mHealth application (called MyChemoCare) in a prospective trial of cancer patients (n=60) who are receiving chemotherapy for colorectal cancer at the University of Michigan Comprehensive Cancer Center.
Interventions
- DEVICE MyChemoCare iPad application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02460822
The ClinicalTrials.gov registry entry for NCT02460822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyChemoCare iPad application is the first listed.
NCT02460822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02460822 about?
NCT02460822 is a clinical study titled "Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management". This research project addresses critical gaps in cancer symptom management through the creation of a mobile chemotherapy symptom management application. This application will assess for the presence and severity of common chemotherapy side-effects and provide personally tailored symptom-related vide...
What is the current status of trial NCT02460822?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-10. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02460822?
The interventions under investigation include: MyChemoCare iPad application (DEVICE).
Who is sponsoring clinical trial NCT02460822?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.